Policy Comments
The priority legislative and regulatory issues that the Cancer Policy Institute focuses on are driven by policy pillars that are centered around the values, needs, and preferences of individuals impacted by cancer. We work in conjunction with patients, patient advocacy organizations, medical associations, and other stakeholders to advance policies aimed at improving access to, affordability of, and quality of care across the cancer continuum.
Cancer Support Community is joined by other cancer advocacy organizations in strongly opposing provisions in the CMS interim final rule that create unnecessary documentation, verification, and administrative barriers for medically frail individuals and people with serious or complex medical conditions.
As a result of our second annual IRA Summit, CSC sent a group letter to CMS Administrator Dr. Oz, including a roadmap of patient-centered principles to guide and inform engagement with CMS and other policymakers.
The 340B Drug Pricing Program is a federally funded program that allows certain hospitals and clinics (“covered entities”) that serve many uninsured and low-income patients to buy prescription drugs directly from drug manufacturers at a much lower cost.
We, the undersigned organizations, collectively represent a diverse community of individuals including patients, survivors, and caregivers who are impacted by cancer and other complex conditions including autoimmune, cardiovascular, gastrointestinal, and rheumatological illnesses. We are focused on bringing together patients and their loved ones, advocates, and policy experts to ensure that the patient voice plays an integral role in federal and state policymaking impacting health care access, patient experiences, and patient outcomes.
Group letter encouraging CMS to extend the 10-digit claims processing screens policy to community settings to ensure timely reimbursement and allow physicians to choose the best care site for their patients without billing constraints
Group letter urging Congress to permanently extend the ACA’s enhanced advance premium tax credits (APTCs) before they expire at the end of 2025
Group letter to Congressional leadership supporting passage of the Safe Step Act in any final PBM reform or end-of-year legislative package.
Sign-on letter commenting on the principal illness navigation (PIN) provisions of the CY 2025 CMS Physician Fee Schedule (PFS) proposed rule.
Group letter to CMS and HHS commenting on CMS' CY 2025 Physician Fee Schedule (PFS) Principle Illness Navigation provisions